ClinicalTrials.gg
RecruitingNCT06037083PEACEUpdated Mar 30, 2026

Post-Extubation Assessment of Clinical Stability in ELBW Infants

An observational study in Extremely Low Birth Weight Infants, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Recruiting at 2 sites in Canada. Open to participants aged Up to 28 Weeks. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Observational

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
Up to 28 Weeks
Sex
All
01

Study summary

This is an observational, proof-of-concept, feasibility study that aims to evaluate the feasibility of a monitoring system that integrates clinical data, high-resolution waveforms from the bedside monitor, regional oxygenation (via cerebral and splanchnic near-infrared spectroscopy), and regional ventilation (via electrical impedance tomography) from 20 extremely low birth weight infants at high-risk of reintubation.

Read the detailed description

The primary aim of this proof-of-concept study is to evaluate the feasibility and acceptance of a monitoring system that integrates clinical data and biomedical signals from multiple modalities in a cohort of extremely preterm infants at high-risk of clinical instability on non-invasive respiratory support.

Secondary aims will be to longitudinally describe peripheral oxygen saturation, cerebral oxygen saturation, splanchnic oxygen saturation and regional lung ventilation in extremely low birth weight infants with or without reintubation during the 7 days post extubation.

The application of this multimodal monitoring approach using both clinical and physiological data during the postextubation period will help by making the assessment of clinical stability more comprehensive, more objective, more accurate, more standardized, and more reflective of important end-organ function. Thus, the proposed multimodal monitoring could lead to more informed decisions about reintubation and more individualized treatment plans during this critical period, hence potentially leading to better outcomes.

02

Conditions studied

  • Extremely Low Birth Weight Infants

Browse trials for

Keywords

  • Reintubation
  • Extubation
  • Extremely low birth weight infants
  • Electrical impedance tomography
  • Cerebral and splanchnic oxygenation
  • Near infrared spectroscopy
  • apnea
  • intermittent hypoxia
03

In context

Apnea

282 studies on the registry are indexed under Apnea; 54 are open to participants now.

This study's planned enrollment of 20 is below the median of 60 across 78 observational studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre is the lead sponsor of 421 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 28 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

20 extremely low birth weight preterm infants admitted to the neonatal intensive care unit at the Montreal Children's Hospital and Centre Hospitalier Universitaire Sainte-Justine.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Birth weight \< 1000g and gestational age \< 28+0 weeks,
  • Received mechanical ventilation within the first 72h of life,
  • Undergoing their first planned extubation within the first 6 weeks of life.

Exclusion criteria

Exclusion Criteria:

- Congenital anomalies and congenital heart disorders.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • 20 extremely low birth weight infants

    In addition to the standard care, all participants will be monitored using an extra oxygen saturation probe, two near infrared spectroscopy sensors, and an electrical impedance tomography belt. Data will be continuously collected from extubation to 168 hours postextubation

    Device: Oxygen saturation probe · Device: Near infrared spectroscopy sensors · Device: Electrical impedance tomography

Interventions

  • DeviceOxygen saturation probe

    The high-accuracy oxygen saturation signal will be continuously acquired for 168 hours post extubation from a separate pulse oximeter (Radical-7®, Masimo ROOT platform, MasimoCorp, Irvine, LA).

  • DeviceNear infrared spectroscopy sensors

    The cerebral and splanchnic regional oxygen saturation signals will be acquired continuously for 168h post extubation using two near infrared spectroscopy sensors (Masimo ROOT platform, MasimoCorp, Irvine, LA), one placed on the forehead for cerebral oxygenation and one on the abdomen (for splanchnic oxygenation).

  • DeviceElectrical impedance tomography

    The regional lung ventilation will be measured using Electrical Impedance Tomography (TIMPEL, USA) at three time points: * From 1 hour pre-extubation to 2 hours post extubation (total 3 hours) * Between 24 and 48 hours post extubation (total 3 hours) * Between 72 and 96 hours post extubation (total 3 hours)

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    To evaluate the time frame needed to recruit patients and percentage of eligible infants recruited

    Time frame: 168 hours

  2. Consent rate

    To evaluate the percentage of eligible infants consented

    Time frame: 168 hours

  3. Acceptability of the multimodal monitoring approach

    Acceptability of the multimodal monitoring approach will be evaluated using short anonymous surveys distributed to parents, bedside nurses, and attending clinicians participating in the study.

    Time frame: 168 hours

Secondary outcomes

  1. To describe longitudinal peripheral blood oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation

    The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.

    Time frame: 168 hours

  2. To describe longitudinal cerebral oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation

    The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation, and compared between infants requiring reintubation and those not requiring reintubation during the 7 days after extubation.

    Time frame: 168 hours

  3. To describe longitudinal splanchnic oxygen saturation patterns for infants with and without reintubation during the 7 days post-extubation

    The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.

    Time frame: 168 hours

  4. To describe regional lung ventilation from the immediate pre-extubation period until 72-96 hours post-extubation.

    The variable will be longitudinally described and graphically displayed using mean (standard deviation), median (interquartile range), or number (percentage) for the hour pre-extubation and for each 24-hour bin post-extubation. Repeated measures one-way ANOVA or Friedman test will be used to evaluate for differences in the variables over time.

    Time frame: 96 hours

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06037083
Responsible party
Wissam Shalish (Assistant Professor of Pediatrics, McGill University Neonatologist, Montreal Children's Hospital, McGill University Health Centre/Research Institute of the McGill University Health Centre) — Principal investigator
First posted
Sep 14, 2023
Start date
Oct 29, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Apr 2027 (estimated)
Last update
Mar 30, 2026

Study contacts

Wissam Shalish, MD, PhD
Contact
wissam.shalish@mcgill.ca
+1(514) 4124452 ext. 22341
Wissam Shalish, MD, PhD
principal investigator · McGill University Health Center/Montreal Children's hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion